1. Home
  2. SBFM vs NML Comparison

SBFM vs NML Comparison

Compare SBFM & NML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • NML
  • Stock Information
  • Founded
  • SBFM 2006
  • NML 2012
  • Country
  • SBFM United States
  • NML United States
  • Employees
  • SBFM N/A
  • NML N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • NML Finance/Investors Services
  • Sector
  • SBFM Health Care
  • NML Finance
  • Exchange
  • SBFM Nasdaq
  • NML Nasdaq
  • Market Cap
  • SBFM 4.9M
  • NML 454.4M
  • IPO Year
  • SBFM N/A
  • NML N/A
  • Fundamental
  • Price
  • SBFM $1.35
  • NML $8.21
  • Analyst Decision
  • SBFM Strong Buy
  • NML
  • Analyst Count
  • SBFM 1
  • NML 0
  • Target Price
  • SBFM $15.00
  • NML N/A
  • AVG Volume (30 Days)
  • SBFM 4.3M
  • NML 219.3K
  • Earning Date
  • SBFM 05-19-2025
  • NML 01-01-0001
  • Dividend Yield
  • SBFM N/A
  • NML 9.75%
  • EPS Growth
  • SBFM N/A
  • NML N/A
  • EPS
  • SBFM N/A
  • NML N/A
  • Revenue
  • SBFM $34,874,283.00
  • NML N/A
  • Revenue This Year
  • SBFM $192.48
  • NML N/A
  • Revenue Next Year
  • SBFM N/A
  • NML N/A
  • P/E Ratio
  • SBFM N/A
  • NML N/A
  • Revenue Growth
  • SBFM 44.75
  • NML N/A
  • 52 Week Low
  • SBFM $1.17
  • NML $6.09
  • 52 Week High
  • SBFM $33.60
  • NML $7.33
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 34.08
  • NML 38.94
  • Support Level
  • SBFM $1.17
  • NML $7.70
  • Resistance Level
  • SBFM $1.59
  • NML $8.50
  • Average True Range (ATR)
  • SBFM 0.33
  • NML 0.43
  • MACD
  • SBFM -0.01
  • NML -0.02
  • Stochastic Oscillator
  • SBFM 6.63
  • NML 42.06

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.

Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.

Share on Social Networks: